250 related articles for article (PubMed ID: 7511777)
1. Risperidone for chronic schizophrenia.
Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777
[No Abstract] [Full Text] [Related]
2. Clinical review of risperidone.
Chouinard G; Arnott W
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574
[TBL] [Abstract][Full Text] [Related]
3. Risperidone: integrating research and practice.
Addington D
Br J Hosp Med; 1994 Sep 7-20; 52(5):223-4. PubMed ID: 7529628
[TBL] [Abstract][Full Text] [Related]
4. Risperidone.
Livingston MG
Lancet; 1994 Feb; 343(8895):457-60. PubMed ID: 7508541
[No Abstract] [Full Text] [Related]
5. Risperidone and remoxipride for schizophrenia.
Drug Ther Bull; 1993 Dec; 31(26):101-2. PubMed ID: 7508364
[No Abstract] [Full Text] [Related]
6. Iloperidone for schizophrenia.
Rado J; Janicak PG
Expert Opin Pharmacother; 2010 Aug; 11(12):2087-93. PubMed ID: 20586713
[TBL] [Abstract][Full Text] [Related]
7. New drug offers hope for people with schizophrenia.
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676
[No Abstract] [Full Text] [Related]
8. Risperidone: clinical issues in treatment.
Littrell K; Schultz RE
J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):47-9. PubMed ID: 7519677
[No Abstract] [Full Text] [Related]
9. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
Kopala LC; Honer WG
J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
[No Abstract] [Full Text] [Related]
10. Risperidone: neurochemical, pharmacologic and clinical properties of a new antipsychotic drug.
Keegan D
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S46-52. PubMed ID: 7533051
[TBL] [Abstract][Full Text] [Related]
11. Risperidone in adolescents.
Cozza SJ; Edison DL
J Am Acad Child Adolesc Psychiatry; 1994 Oct; 33(8):1211. PubMed ID: 7527022
[No Abstract] [Full Text] [Related]
12. Novel neuroleptics in schizophrenia: theory and clinical relevance.
Remington GJ
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S43-5. PubMed ID: 7533050
[No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study.
Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T
Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of risperidone in chronic schizophrenic patients.
Borison RL; Diamond B; Pathiraja A; Meibach RC
Psychopharmacol Bull; 1994; 30(2):193-7. PubMed ID: 7530379
[TBL] [Abstract][Full Text] [Related]
15. [New psychopharmacologic alternatives in treatment of schizophrenia].
Bryois C
Schweiz Arch Neurol Psychiatr (1985); 1994; 145(6):19-24. PubMed ID: 7533941
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of risperidone.
Ereshefsky L; Lacombe S
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S80-8. PubMed ID: 7504573
[TBL] [Abstract][Full Text] [Related]
17. Iloperidone for the management of adults with schizophrenia.
Crabtree BL; Montgomery J
Clin Ther; 2011 Mar; 33(3):330-45. PubMed ID: 21600386
[TBL] [Abstract][Full Text] [Related]
18. New advances in the treatment of schizophrenia. Introduction.
Potkin SG
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S1-3. PubMed ID: 18334907
[No Abstract] [Full Text] [Related]
19. Reduction of hospital days in chronic schizophrenic patients treated with risperidone: a retrospective study.
Addington DE; Jones B; Bloom D; Chouinard G; Remington G; Albright P
Clin Ther; 1993; 15(5):917-26. PubMed ID: 7505716
[TBL] [Abstract][Full Text] [Related]
20. New antipsychotic medications: do research results relate to clinical practice?
MacEwan GW
Can J Psychiatry; 1993 Sep; 38 Suppl 3():S75-9. PubMed ID: 7504572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]